
Novel findings on gynaecological cancers will be revealed later this month at the ESMO Congress 2023 in Madrid

Fairtility’s software platform supports reproductive care practitioners as a workflow enhancement and decision support toolset

Even though egg freezing has grown in popularity over the last decade, to many the process remains intense and overwhelming

Gals Bio claims Tulipon can turn women's monthly bleeding into a “biopsy” that can be used to monitor and screen their health

More than 75 per cent of the participants involved in the study reported experiencing changes in their menstrual cycles during the pandemic

Patients have a more than 90 per cent chance of living for five years or more when ovarian cancer is found in its initial stages

Sensapex will integrate its ultra-precise micromanipulators and microscope automation capabilities with IVF2.0’s AI software

Future Fertility’s oocyte tools will be available for automatic integration within the Geri Time-lapse incubator

Patients will be able to have access to specialist health providers trained in menopause and perimenopause care

Daye's diagnostic tampon aims to transform women’s experience when being screened for HPV and STIs

Fairtility has secured the coveted Digital Healthy in the Rising Stars track within women’s health

Ovarian cancer ranks fifth in cancer deaths among women in the US, accounting for more deaths than any other cancer of the female reproductive system

Latin America has captured international attention due to its popularity as a destination for medical tourism and a surging demand for fertility services

Texas-based MDisrupt aims to connect health experts in the US with digital health companies

The new contraceptive method that slows down sperm will first be trialled on women, say researchers

In the US alone, 50 per cent of women over the age of 50 will experience a fracture caused by osteoporosis

The growth gap, the consulting firm argues, poses significant obstacles to delivering effective care to women

FemHealth Ventures aims to invest in women’s health innovations, focusing on drugs, devices, diagnostics, and digital applications

Postpartum depression is thought to affect more than one in every 10 women within a year of giving birth

South Korean researchers developed a biosensor which could detect two high-risk types of HPV commonly associated with cervical cancer